[Federal Register Volume 84, Number 191 (Wednesday, October 2, 2019)]
[Notices]
[Pages 52539-52540]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-21395]


-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (19-058)]


Notice of Intent To Grant a Partially Exclusive Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of intent to grant a partially-exclusive patent license.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice of its intent to grant a partially 
exclusive patent license in the United States to practice the invention 
described and claimed in U.S. Patent 9,770,405 entitled, 
``Biocompatible Capsules and Methods of Making,'' to Capcell Biologics, 
Inc. having its principal place of business in New York, NY. The fields 
of use may be limited to health and medicine. The patent rights in this 
invention, directed to Health, Medicine, and Biotechnology, have been 
assigned to the United States of America as represented by the 
Administrator of the National Aeronautics and Space Administration. 
NASA has not yet made a determination to grant the requested license 
and may deny the requested license even if no objections are submitted 
within the comment period.

DATES: The prospective partially exclusive license may be granted 
unless NASA receives written objections, including evidence and 
argument no

[[Page 52540]]

later than October 17, 2019 that establish that the grant of the 
license would not be consistent with the requirements regarding the 
licensing of federally owned inventions as set forth in the Bayh-Dole 
Act and implementing regulations. Competing applications completed and 
received by NASA no later than October 17, 2019 will also be treated as 
objections to the grant of the contemplated partially exclusive 
license. Objections submitted in response to this notice will not be 
made available to the public for inspection and, to the extent 
permitted by law, will not be released under the Freedom of Information 
Act.

ADDRESSES: Objections relating to the prospective license may be 
submitted to Patent Counsel, Office of Chief Counsel, NASA Ames 
Research Center, Mail Stop 202A-4, Moffett Field, CA 94035-1000. (650) 
604-0887; Fax (650) 604-2767.

FOR FURTHER INFORMATION CONTACT: Robert M. Padilla, Chief Patent 
Counsel, Office of Chief Counsel, NASA Ames Research Center, Mail Stop 
202A-4, Moffett Field, CA 94035-1000. (650) 604-0887; Fax (650) 604-
2767.

SUPPLEMENTARY INFORMATION: This Notice of Intent to Grant a Partially-
Exclusive Patent License is issued in accordance with 35 U.S.C. 209(e) 
and 37 CFR 404.7(a)(1)(i). The patent rights in this invention have 
been assigned to the United States of America as represented by the 
Administrator of the National Aeronautics and Space Administration. The 
prospective partially-exclusive patent license will comply with the 
requirements of 35 U.S.C. 209 and 37 CFR. 404.7.
    Information about other NASA inventions available for licensing can 
be found online at http://technology.nasa.gov.

William T. McMurry,
Deputy General Counsel.
[FR Doc. 2019-21395 Filed 10-1-19; 8:45 am]
BILLING CODE 7510-13-P